Erika Evangelina Coronado-Cerda

Erika Evangelina Coronado-Cerda

Auto-generated profile, based on publicly available information

Erika Evangelina Coronado-Cerda

Universidad del Valle de México, Campus Cumbres, Departamento de Ciencias de la Salud, Av. Las Palmas, 5500, Colonia Cima de las Cumbres, Monterrey, Nuevo León, C.P. 64610, Mexico

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Molecular Immunology
Verified
Journal Article
Closed access
Gerardo Garcia-GonzalezGerardo Garcia-Gonzalez
Gerardo Garcia-Gonzalez
ASAlejandro Sanchez
Alejandro Sanchez
RHRomel Hernández-Bello
Romel Hernández-Bello
GGGloria M. González
Gloria M. González
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
JPJosé Prisco Palma-Nicolás
José Prisco Palma-Nicolás

9 March 2021 in EXCLI Journal
Verified
Journal Article
Open access
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
SSSilvia Santana-Krímskaya
Silvia Santana-Krímskaya
LMLuis Mario Madrigal-De-León
Luis Mario Madrigal-De-León
ECErika Evangelina Coronado-Cerda
Erika Evangelina Coronado-Cerda
DTDIANA ZARATE TRIVIÑO
DIANA ZARATE TRIVIÑO
CRCristina Padilla Rodríguez-Padilla
Cristina Padilla Rodríguez-Padilla
Glioblastoma multiforme is a malignant neoplasm of the brain with poor prognosis. The first-line drug against glioblastoma is the alkylating agent temozolamide (TMZ); unfortunately, treatment resistance and tumor re-incidence are common. In some cases, immunogenic cell death (ICD) inducers can decrease treatment resistance and tumor recurrence by stimulating an antitumor specific immune response. Not all ICD inducers, however, are suitable for glioma patients because of the low permeability of the blood-brain barrier (BBB). Panobinostat (PAN), a histone deacetylase inhibitor and Lophophora williamsii (LW) extract can pass through the BBB and have antitumor properties. The aim of this study is to evaluate the cytotoxic potential of TMZ, PAN and LW extract against the glioma C6 cell line, and its role in the release of damage-associated molecular patterns (DAMPs), which is a hallmark of ICD. Our results indicate that all treatments induce cellular death in a time- and concentration-dependent manner, and that PAN and LW extract induce apoptosis, whereas TMZ induces apoptosis and necrosis. Also, that some of the treatments and their sequential administration induce the release of DAMPs. Furthermore, in a rat glioma model, we observed that all treatments decreased tumor volume, but the in vivo cell death mechanism was not ICD. Our findings indicate that TMZ, PAN, and LW combination have a cytotoxic effect against glioma cells but do not induce ICD.

28 December 2016 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
EME. Mendoza-Gamboa
E. Mendoza-Gamboa
DTDIANA ZARATE TRIVIÑO
DIANA ZARATE TRIVIÑO
ECE. E. Coronado-Cerda
E. E. Coronado-Cerda
JAJ. M. Alcocer-González
J. M. Alcocer-González
CRC. Rodríguez-Padilla
C. Rodríguez-Padilla
Colloidal silver (AgC) is currently used by humans and it can be internalized through inhalation, injection, ingestion, and dermal contact. However, there is limited information about immunological activity; more investigations using colloidal silver are needed. In the present study, the effects of AgC (17.5 ng/mL) on immunological parameters (proliferation and immunophenotyping) using human peripheral blood mononuclear cells (PBMC) and macrophages (phagocytosis) and cytotoxicity on leukemia and lymphoma cancer cell lines (1.75 to 17.5 ng/mL) were investigated. AgC was observed to significantly (p<0.05) decrease interleukin-2 (IL-2) production and proliferation induced by phytohemagglutinin or concanavalin A in PBMC without affecting its cell viability but with cytotoxic effect on cancer cells. IL-2, IL-4, IL-6, IL-10, INF-γ, and IL-17A cytokines production and CD3+, CD3−CD19+, CD3+CD4+, CD3+CD8+, and CD16+CD56+ PBMC phenotypes were not affected by AgC. The present study demonstrates that colloidal silver is harmless and nontoxic to the immune system cells and its ability to interfere with the immune response by decreasing cell proliferation when stimulated with mitogens demonstrated the antilymphoproliferative potential of AgC.